Citation Impact
Citing Papers
Prediction of Individual Brain Maturity Using fMRI
2010 StandoutScience
MONARCH 1, A Phase II Study of Abemaciclib, a CDK4 and CDK6 Inhibitor, as a Single Agent, in Patients with Refractory HR+/HER2− Metastatic Breast Cancer
2017
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
PARP inhibitors: Synthetic lethality in the clinic
2017 StandoutScience
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study
2011
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
2017 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab Therapy
2010
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
2010 Standout
Inkjet-printed unclonable quantum dot fluorescent anti-counterfeiting labels with artificial intelligence authentication
2019 Standout
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
2013 Standout
Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial
2009
Triple-Negative Breast Cancer
2010 Standout
Support Vector Machine-based method for predicting subcellular localization of mycobacterial proteins using evolutionary information and motifs
2007
Support Vector Machines and Kernels for Computational Biology
2008
The re-emergence of natural products for drug discovery in the genomics era
2015 Standout
Pancreatic cancer
2004 Standout
The Precision-Recall Plot Is More Informative than the ROC Plot When Evaluating Binary Classifiers on Imbalanced Datasets
2015 Standout
How many drug targets are there?
2006 Standout
Markers predicting clinical benefit in breast cancer from microtubule-targeting agents
2007
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
2008 Standout
Systems chemical biology
2007
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
CPC: assess the protein-coding potential of transcripts using sequence features and support vector machine
2007 Standout
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
2011
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Ranking predicted protein structures with support vector regression
2007 StandoutNobel
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
2016 Standout
A multicenter phase II study of XRP6258 administered as a 1-h i.v. infusion every 3 weeks in taxane-resistant metastatic breast cancer patients
2008
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Cytotoxic chemotherapy: Still the mainstay of clinical practice for all subtypes metastatic breast cancer
2016
Drug repurposing: progress, challenges and recommendations
2018 Standout
Therapeutic Targets: Progress of Their Exploration and Investigation of Their Characteristics
2006
Prediction of potential drug targets based on simple sequence properties
2007
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Neurological adverse effects caused by cytotoxic and targeted therapies
2009
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness
2007
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Network-based function prediction and interactomics: The case for metabolic enzymes
2010
A composite score for predicting errors in protein structure models
2006
Applications of machine learning in drug discovery and development
2019 Standout
Continuous Distributed Representation of Biological Sequences for Deep Proteomics and Genomics
2015
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
2012 Standout
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
2010 Standout
Ixabepilone for the treatment of breast cancer
2011
Does Drug-target Have a Likeness?
2007
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
Lessons learned from independent central review
2008
The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
2010 Standout
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Pancreatic cancer
2011 Standout
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study
2009
DeepFunc: A Deep Learning Framework for Accurate Prediction of Protein Functions from Protein Sequences and Interactions
2019
Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study
2009
PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes
2010 Standout
Ixabepilone: targeting βIII-tubulin expression in taxane-resistant malignancies
2009
Multistage Microfluidic Platform for the Continuous Synthesis of III–V Core/Shell Quantum Dots
2018 StandoutNobel
Sex differences in non-alcoholic fatty liver disease: hints for future management of the disease
2020
Nanozymes: Classification, Catalytic Mechanisms, Activity Regulation, and Applications
2019 Standout
Blinded Independent Central Review of Progression-Free Survival in Phase III Clinical Trials: Important Design Element or Unnecessary Expense?
2008
Seedless Continuous Injection Synthesis of Indium Phosphide Quantum Dots as a Route to Large Size and Low Size Dispersity
2020 StandoutNobel
Mechanistic Insights and Controlled Synthesis of Radioluminescent ZnSe Quantum Dots Using a Microfluidic Reactor
2018 StandoutNobel
Carbon Dots for In Vivo Bioimaging and Theranostics
2019
Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
2011
Breast Cancer Treatment
2019 Standout
Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
2008
NCCN Task Force Report: Management of Neuropathy in Cancer
2009
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Learned protein embeddings for machine learning
2018 StandoutNobel
Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane
2009
The STRING database in 2023: protein–protein association networks and functional enrichment analyses for any sequenced genome of interest
2022 Standout
Protein function prediction via graph kernels
2005
Phosphorescent Carbon Dots for Highly Efficient Oxygen Photosensitization and as Photo-oxidative Nanozymes
2018
Enhancing Light Absorption and Charge Transfer Efficiency in Carbon Dots through Graphitization and Core Nitrogen Doping
2017
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
2014 Standout
Cocatalysts for Selective Photoreduction of CO2into Solar Fuels
2019 Standout
Disease-Free Survival According to Degree of HER2 Amplification for Patients Treated With Adjuvant Chemotherapy With or Without 1 Year of Trastuzumab: The HERA Trial
2009
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Colloidal Synthesis of Semiconductor Quantum Dots toward Large-Scale Production: A Review
2018
Physical unclonable functions generated through chemical methods for anti-counterfeiting
2017 Standout
Works of Can Cai being referenced
Knockdown of hepatic aquaglyceroporin-9 alleviates high fat diet-induced non-alcoholic fatty liver disease in rats
2013
Prediction of transporter family from protein sequence by support vector machine approach
2005
SVM-Prot: web-based support vector machine software for functional classification of a protein from its primary sequence
2003
Protein function classification via support vector machine approach
2003
Efficacy and Safety of Ixabepilone (BMS-247550) in a Phase II Study of Patients With Advanced Breast Cancer Resistant to an Anthracycline, a Taxane, and Capecitabine
2007
Triple‐Mode Emission of Carbon Dots: Applications for Advanced Anti‐Counterfeiting
2016